| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,862 |
18,369 |
$3.89M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12,561 |
11,001 |
$2.46M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
13,432 |
3,104 |
$1.11M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,916 |
3,527 |
$652K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,294 |
1,117 |
$565K |
| 97750 |
|
3,295 |
1,683 |
$533K |
| 99201 |
|
1,875 |
1,180 |
$532K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
570 |
559 |
$424K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,817 |
616 |
$415K |
| 97139 |
|
7,638 |
1,477 |
$369K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,123 |
1,122 |
$354K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,776 |
2,476 |
$344K |
| 70450 |
Computed tomography, head or brain; without contrast material |
813 |
796 |
$316K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,136 |
2,926 |
$243K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,301 |
2,063 |
$212K |
| 80053 |
Comprehensive metabolic panel |
15,134 |
13,502 |
$208K |
| J3490 |
Unclassified drugs |
12,777 |
7,250 |
$176K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,228 |
2,116 |
$176K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,213 |
1,183 |
$160K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,161 |
1,962 |
$155K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,725 |
1,685 |
$143K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,158 |
12,645 |
$138K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,209 |
5,126 |
$118K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,026 |
2,019 |
$101K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,654 |
1,508 |
$101K |
| 80061 |
Lipid panel |
4,635 |
4,610 |
$84K |
| 71046 |
Radiologic examination, chest; 2 views |
1,339 |
1,297 |
$79K |
| 71045 |
Radiologic examination, chest; single view |
2,298 |
2,165 |
$78K |
| J2704 |
Injection, propofol, 10 mg |
1,730 |
1,445 |
$76K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
94 |
93 |
$73K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
951 |
950 |
$54K |
| 97010 |
|
398 |
104 |
$54K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,198 |
1,186 |
$48K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,191 |
1,178 |
$48K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,466 |
3,155 |
$48K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,101 |
1,694 |
$43K |
| 83605 |
|
2,988 |
2,765 |
$43K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,860 |
2,557 |
$41K |
| 85027 |
|
3,154 |
2,896 |
$39K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
185 |
182 |
$38K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,815 |
2,609 |
$37K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,853 |
2,841 |
$36K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
172 |
171 |
$31K |
| 84484 |
|
2,198 |
1,986 |
$30K |
| 72100 |
|
289 |
285 |
$28K |
| 83690 |
|
3,059 |
2,802 |
$27K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,061 |
2,769 |
$26K |
| 73030 |
|
284 |
276 |
$26K |
| 99070 |
|
1,598 |
1,325 |
$25K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,309 |
2,153 |
$24K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
404 |
362 |
$24K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
477 |
472 |
$23K |
| 84439 |
|
2,038 |
2,023 |
$22K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
131 |
118 |
$21K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
902 |
827 |
$20K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,583 |
1,476 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
970 |
964 |
$19K |
| 81001 |
|
3,121 |
2,915 |
$19K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
82 |
75 |
$18K |
| 0450 |
Emergency room services |
186 |
172 |
$18K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,302 |
1,050 |
$17K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
783 |
385 |
$16K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
114 |
112 |
$16K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
26 |
26 |
$16K |
| 76830 |
Ultrasound, transvaginal |
78 |
75 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
26 |
26 |
$14K |
| 87070 |
|
1,003 |
981 |
$14K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
841 |
753 |
$14K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
13 |
$13K |
| 86703 |
|
429 |
428 |
$13K |
| 87631 |
|
113 |
108 |
$12K |
| 73562 |
|
144 |
143 |
$11K |
| 87186 |
|
722 |
690 |
$11K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
973 |
959 |
$11K |
| 85730 |
|
1,354 |
1,299 |
$11K |
| 74178 |
|
12 |
12 |
$11K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
51 |
51 |
$10K |
| 85610 |
|
1,844 |
1,688 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
25 |
25 |
$9K |
| 86803 |
|
560 |
559 |
$9K |
| 83735 |
|
1,224 |
1,092 |
$9K |
| 73610 |
|
110 |
106 |
$8K |
| 83880 |
|
255 |
235 |
$8K |
| 73630 |
|
96 |
92 |
$8K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
77 |
74 |
$7K |
| 87040 |
|
340 |
324 |
$7K |
| 76641 |
|
28 |
28 |
$6K |
| 87077 |
|
519 |
506 |
$6K |
| 81003 |
|
1,586 |
1,538 |
$6K |
| 85007 |
|
1,148 |
1,012 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
393 |
340 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
21 |
21 |
$4K |
| 87899 |
|
351 |
350 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
58 |
58 |
$3K |
| 73130 |
|
42 |
40 |
$3K |
| 73110 |
|
41 |
38 |
$3K |
| 85652 |
|
704 |
676 |
$3K |
| 86850 |
|
713 |
684 |
$3K |
| 86901 |
|
752 |
722 |
$3K |
| 86900 |
|
740 |
710 |
$2K |
| 82746 |
|
126 |
126 |
$2K |
| 86592 |
|
545 |
544 |
$2K |
| 82962 |
|
420 |
364 |
$2K |
| 82550 |
|
101 |
100 |
$2K |
| 87205 |
|
197 |
194 |
$2K |
| 86141 |
|
66 |
65 |
$2K |
| 86780 |
|
96 |
95 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$1K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
128 |
96 |
$1K |
| S0028 |
Injection, famotidine, 20 mg |
234 |
230 |
$1K |
| 82607 |
|
39 |
39 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
34 |
34 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
155 |
135 |
$1K |
| Z7502 |
|
28 |
28 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
67 |
67 |
$991.96 |
| 80076 |
|
39 |
39 |
$892.32 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
64 |
63 |
$852.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
101 |
92 |
$844.87 |
| 83540 |
|
123 |
120 |
$676.13 |
| 73140 |
|
12 |
12 |
$659.78 |
| 12001 |
|
12 |
12 |
$568.08 |
| 86769 |
|
13 |
13 |
$547.69 |
| 86140 |
|
128 |
127 |
$542.80 |
| 83550 |
|
67 |
64 |
$435.57 |
| 87653 |
|
14 |
14 |
$427.28 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
63 |
61 |
$421.22 |
| 85379 |
|
50 |
50 |
$380.91 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$312.08 |
| 82274 |
|
16 |
16 |
$228.64 |
| 87340 |
|
24 |
24 |
$225.26 |
| 84153 |
|
13 |
13 |
$179.85 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
28 |
26 |
$139.65 |
| 82728 |
|
12 |
12 |
$132.77 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
14 |
12 |
$110.46 |
| 84100 |
|
14 |
13 |
$63.15 |
| 84703 |
|
12 |
12 |
$21.50 |